# The Role of Stress Neuromodulators in Decision Making Under Risk (Part II)

> **NCT05318248** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 82 (actual)

## Conditions studied

- Stress

## Interventions

- **DRUG:** Clonidin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05318248
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2023-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05318248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05318248, "The Role of Stress Neuromodulators in Decision Making Under Risk (Part II)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT05318248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*